We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

31 hedge funds and large institutions have $3.25M invested in Microbot Medical in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 30 → 31 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

0.52% less ownership

Funds ownership: 14.76% → 14.24% (-0.52%)

1% less capital invested

Capital invested by funds: $3.27M → $3.25M (-$19K)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$29.2K
2
GI
Gradient Investments
Minnesota
+$11.7K
3
Victory Capital Management
Victory Capital Management
Texas
+$3.85K
4
AIC
Ameritas Investment Company
Nebraska
+$1.09K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$567

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$67K
2
JP Morgan Chase
JP Morgan Chase
New York
-$45K
3
Renaissance Technologies
Renaissance Technologies
New York
-$31.2K
4
Morgan Stanley
Morgan Stanley
New York
-$11.4K
5
BlackRock
BlackRock
New York
-$3.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.07M -$31.2K -5,338 -3%
BlackRock
2
BlackRock
New York
$970K -$3.09K -528 -0.3%
SM
3
Sabby Management
Florida
$442K – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$245K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$221K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$140K +$12 +2 +0%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$70K – – –
Bank of Montreal
8
Bank of Montreal
Ontario, Canada
$27K +$29.2K +5,000 +250,000%
Morgan Stanley
9
Morgan Stanley
New York
$23K -$11.4K -1,943 -31%
SPIA
10
Steward Partners Investment Advisory
New York
$15K – – –
UBS Group
11
UBS Group
Switzerland
$11K -$1.47K -252 -11%
GI
12
Gradient Investments
Minnesota
$11K +$11.7K +2,000 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$4K +$567 +97 +16%
Victory Capital Management
14
Victory Capital Management
Texas
$3K +$3.85K +659 New
Wells Fargo
15
Wells Fargo
California
$1K – – –
AIC
16
Ameritas Investment Company
Nebraska
$1K +$1.09K +186 New
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$21 – – –
RE
18
RBC Europe
United Kingdom
$5 – – –
Millennium Management
19
Millennium Management
New York
– -$67K -13,063 Closed
JP Morgan Chase
20
JP Morgan Chase
New York
– -$45K -9,068 Closed
Deutsche Bank
21
Deutsche Bank
Germany
– -$1K -338 Closed
Credit Agricole
22
Credit Agricole
France
– +$6 +1 New
IA
23
IFP Advisors
Florida
– +$6 +1 New
Barclays
24
Barclays
United Kingdom
– +$47 +8 +800%
BCM
25
Bourgeon Capital Management
Connecticut
– +$64 +11 New

MBOT Hedge Fund Activity: Q3 2019 in Review

31 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2019, worth a combined $3.25M — down 0.58% from $3.27M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBOT positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $29.2K. The largest seller was Millennium Management, exiting entirely with an estimated $67K sold.

  • 31 institutional investors held Microbot Medical (MBOT) as of Q3 2019, up from 30 in Q2 2019.
  • Funds reported $3.25M of Microbot Medical stock for Q3 2019, down 0.58% quarter-over-quarter.
  • 6 funds opened new Microbot Medical positions in Q3 2019 and 5 closed out, a net change of +1 holder.
  • The largest Microbot Medical buyer in Q3 2019 was Bank of Montreal, an estimated $29.2K added.
  • The largest Microbot Medical seller in Q3 2019 was Millennium Management, an estimated $67K sold.

Based on aggregated 13F filings for Q3 2019.